GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Dhanuka Agritech Ltd
Results- Unaudited Financial Results for the Quarter ended June 30, 2026.
RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 03 Aug 2026, 02:33 PM IST  ·  BSE ID: 8989f7c5-fac3-4dbe-9010-aad4ea272779
View Original BSE Filing (PDF)
💡
In Simple Terms
Dhanuka Agritech announced its latest quarterly financial results and plans to build a new Rs. 200 Crore pesticide factory.
🤖 AI Summary
  • Dhanuka Agritech reported unaudited Net Profit of Rs. 3,630.44 Lacs for the quarter ended June 30, 2026.
  • Revenue from Operations for Q1 FY27 stood at Rs. 46,192.81 Lacs, compared to Rs. 52,828.81 Lacs in Q1 FY26.
  • Board approved an investment of up to Rs. 200 Crore for a new pesticide manufacturing unit in Nagpur, Maharashtra.
  • The new manufacturing unit is projected to add 23,000 MT/Annum capacity, operational by March/April 2028.
  • A loan of up to Rs. 15 Crore was approved for Dhanuka Employee Stock Benefits Trust for a SAR Plan.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
46,192.81 Lacs
Revenue from Operations (Q1 FY26)
52,828.81 Lacs
-12.63%
Profit for the period (Q1 FY27)
3,630.44 Lacs
Profit for the period (Q1 FY26)
5,550.34 Lacs
-34.69%
Investment for New Pesticide Unit
Rs. 200 Crore
Loan for Employee Trust
Rs. 15 Crore
Basic EPS (Q1 FY27)
8.06
Basic EPS (Q1 FY26)
12.31
-34.52%
🏢 How This Affects the Company
📈
Business Impact
The new pesticide manufacturing unit at Nagpur, Maharashtra, with a proposed capacity of 23,000 MT/Annum, positions the company closer to South, East, and Central Indian markets, supporting reduced lead time.
💰
Financial Impact
An investment of up to Rs. 200 Crore for the new unit and a loan of up to Rs. 15 Crore for the employee trust will impact capital expenditure and cash flow, financed through internal accruals and/or debt.
⚙️
Operational Impact
The new plant, expected to be operational by March/April 2028, will significantly expand the company's production capacity and optimize logistics for distribution in key regions.
⚠️
Risk Impact
The capital outlay for the new plant introduces project execution risks and market demand risks until the plant becomes operational in 2028.
👥 What This Means For Shareholders
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are indirectly affected by the company's capital allocation decisions for expansion and employee benefit plans, impacting future earnings potential and equity structure.
🔍
Management Signal
Management is signaling a focus on expanding manufacturing capacity, optimizing logistics, and enhancing employee incentives for long-term growth.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Updates on progress and timeline for the Nagpur pesticide manufacturing unit by March/April 2028.
Details of funding mix (internal accruals/debt) for the Rs. 200 Crore investment.
Information on the utilization and impact of the Rs. 15 Crore loan for the employee SAR Plan.
MEDIUM RISK Significant capital expenditure for the new unit involves execution and market demand risks until 2028.
💡 Investor Takeaway
Dhanuka Agritech reported Q1 FY27 Net Profit of Rs. 3,630.44 Lacs, down from Rs. 5,550.34 Lacs in Q1 FY26. The Board approved a Rs. 200 Crore investment for a new pesticide manufacturing unit in Nagpur, adding 23,000 MT/Annum capacity by March/April 2028. A Rs. 15 Crore loan for an employee SAR Plan was also approved.
⚖️ Strengths & Concerns

✅ Positives

  • Company commits up to Rs. 200 Crore for a new pesticide manufacturing unit, adding 23,000 MT/Annum capacity.
  • Initiation of 'Dhanuka Stock Appreciation Rights Plan, 2026' with Rs. 15 Crore loan may enhance employee retention.

⚠️ Concerns

  • Revenue from Operations declined to Rs. 46,192.81 Lacs in Q1 FY27 from Rs. 52,828.81 Lacs in Q1 FY26.
  • Profit for the period decreased to Rs. 3,630.44 Lacs in Q1 FY27 from Rs. 5,550.34 Lacs in Q1 FY26.
📅 Company Track Record
Dhanuka Agritech's previous filing on August 3, 2026, had already indicated the approval for granting a loan to the proposed Dhanuka Employee Stock Benefits Trust and the new pesticide unit, with the board meeting on July 28, 2026, scheduled to approve Q1 FY27 results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Dhanuka Agritech's Net Profit for the quarter ended June 30, 2026?
Dhanuka Agritech's Net Profit for the quarter ended June 30, 2026, was Rs. 3,630.44 Lacs.
What is the investment approved for the new pesticide manufacturing unit by Dhanuka Agritech?
Dhanuka Agritech's Board approved an investment of up to Rs. 200 Crore for setting up a new pesticide manufacturing unit at Nagpur, Maharashtra.
What is the proposed capacity addition and operational timeline for the new plant?
The proposed new plant will add 23,000 MT/Annum capacity and is expected to be operational by March/April 2028.
What loan amount was approved for the Dhanuka Employee Stock Benefits Trust?
A loan of up to Rs. 15 Crore was approved to the proposed Dhanuka Employee Stock Benefits Trust for the 'Dhanuka Stock Appreciation Rights Plan, 2026'.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.